These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35569780)

  • 1. Changes in immune function and immunomodulatory treatments of septic patients.
    Xu Z; Liu A; Yang L; Zhang B; Zheng F; Zhang J; Zhan J
    Clin Immunol; 2022 Jun; 239():109040. PubMed ID: 35569780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concise Review: Mesenchymal Stromal/Stem Cells: A New Treatment for Sepsis and Septic Shock?
    Laroye C; Gibot S; Reppel L; Bensoussan D
    Stem Cells; 2017 Dec; 35(12):2331-2339. PubMed ID: 28856759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting the host response in sepsis: current approaches and future evidence.
    Bode C; Weis S; Sauer A; Wendel-Garcia P; David S
    Crit Care; 2023 Dec; 27(1):478. PubMed ID: 38057824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunomodulatory function of adenosine in sepsis.
    Zhang T; Yu-Jing L; Ma T
    Front Immunol; 2022; 13():936547. PubMed ID: 35958599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Rationale for Endotoxin Removal with Polymyxin B Immobilized Fiber Column (PMX) for Septic Shock.
    Shoji H; Opal SM
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulation during sepsis in organ transplanted children.
    Angele MK; Loehe F; Faist E
    Minerva Pediatr; 2005 Oct; 57(5):259-68. PubMed ID: 16205609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sepsis and septic shock: pathophysiological and cardiovascular background as basis for therapy.
    De Kock I; Van Daele C; Poelaert J
    Acta Clin Belg; 2010; 65(5):323-9. PubMed ID: 21128559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression from sepsis to septic shock and time to treatments in preterm infants with late-onset sepsis.
    Gorantiwar S; de Waal K
    J Paediatr Child Health; 2021 Dec; 57(12):1905-1911. PubMed ID: 34085340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality in Patients With Septic Shock by Multidrug Resistant Bacteria: Risk Factors and Impact of Sepsis Treatments.
    Busani S; Serafini G; Mantovani E; Venturelli C; Giannella M; Viale P; Mussini C; Cossarizza A; Girardis M
    J Intensive Care Med; 2019 Jan; 34(1):48-54. PubMed ID: 28100110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials of immunomodulatory therapies in severe sepsis and septic shock.
    Vincent JL; Sun Q; Dubois MJ
    Clin Infect Dis; 2002 Apr; 34(8):1084-93. PubMed ID: 11914997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time- and fluid-sensitive resuscitation for hemodynamic support of children in septic shock: barriers to the implementation of the American College of Critical Care Medicine/Pediatric Advanced Life Support Guidelines in a pediatric intensive care unit in a developing world.
    Oliveira CF; Nogueira de Sá FR; Oliveira DS; Gottschald AF; Moura JD; Shibata AR; Troster EJ; Vaz FA; Carcillo JA
    Pediatr Emerg Care; 2008 Dec; 24(12):810-5. PubMed ID: 19050666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sepsis and septic shock. II. Treatment.
    Mayer J; Hajek R; Vorlicek J; Tomiska M
    Support Care Cancer; 1995 Mar; 3(2):111-9. PubMed ID: 7773578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New perspectives on immunomodulatory therapy for bacteraemia and sepsis.
    Opal SM
    Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S70-3. PubMed ID: 21129935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive treatments for the management of septic shock - a narrative review of the current evidence.
    Donovan K; Shah A; Day J; McKechnie SR
    Anaesthesia; 2021 Sep; 76(9):1245-1258. PubMed ID: 33421029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging therapies for sepsis and septic shock.
    Oh HM
    Ann Acad Med Singap; 1998 Sep; 27(5):738-43. PubMed ID: 9919353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.
    Patil NK; Bohannon JK; Sherwood ER
    Pharmacol Res; 2016 Sep; 111():688-702. PubMed ID: 27468649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel treatment strategy for sepsis and septic shock based on the interactions between prostanoids, nitric oxide, and 20-hydroxyeicosatetraenoic acid.
    Tunctan B; Korkmaz B; Sari AN; Kacan M; Unsal D; Serin MS; Buharalioglu CK; Sahan-Firat S; Schunck WH; Falck JR; Malik KU
    Antiinflamm Antiallergy Agents Med Chem; 2012; 11(2):121-50. PubMed ID: 23013331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sepsis: time has come to focus on the later stages.
    Schefold JC; Hasper D; Volk HD; Reinke P
    Med Hypotheses; 2008 Aug; 71(2):203-8. PubMed ID: 18448264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombin replacement in patients with sepsis and septic shock.
    Giudici D; Baudo F; Palareti G; Ravizza A; Ridolfi L; D' Angelo A
    Haematologica; 1999 May; 84(5):452-60. PubMed ID: 10329925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.